BSE Live
Apr 21, 16:01Prev. Close
32.00
Open Price
33.58
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Profit & Loss account of Prism Medico and Pharmacy (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 0.63 | 2.93 | 1.27 | 8.44 | 16.76 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 0.63 | 2.93 | 1.27 | 8.44 | 16.76 | |
| Total Operating Revenues | 0.63 | 2.93 | 1.27 | 8.44 | 16.76 | |
| Other Income | 0.02 | 0.12 | 0.00 | 0.00 | 0.00 | |
| Total Revenue | 0.65 | 3.05 | 1.27 | 8.44 | 16.76 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 0.00 | 0.00 | 1.14 | 10.55 | 0.00 | |
| Purchase Of Stock-In Trade | 0.45 | 2.56 | 0.00 | 0.00 | 21.47 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.00 | 0.00 | 0.00 | -1.92 | -4.80 | |
| Employee Benefit Expenses | 0.04 | 0.03 | 0.05 | 0.19 | 0.17 | |
| Finance Costs | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | |
| Depreciation And Amortisation Expenses | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Other Expenses | 0.22 | 0.47 | 0.18 | 0.12 | 0.09 | |
| Total Expenses | 0.71 | 3.08 | 1.37 | 8.94 | 16.94 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -0.07 | -0.03 | -0.10 | -0.50 | -0.18 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -0.07 | -0.03 | -0.10 | -0.50 | -0.18 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -0.02 | -0.01 | -0.03 | -0.13 | -0.05 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | -0.02 | -0.01 | -0.03 | -0.13 | -0.05 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -0.05 | -0.02 | -0.08 | -0.37 | -0.13 | |
| Profit/Loss From Continuing Operations | -0.05 | -0.02 | -0.08 | -0.37 | -0.13 | |
| Profit/Loss For The Period | -0.05 | -0.02 | -0.08 | -0.37 | -0.13 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -0.08 | -0.05 | -0.13 | -0.61 | -0.21 | |
| Diluted EPS (Rs.) | -0.08 | -0.05 | -0.13 | -0.61 | -0.21 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
13.06.2025
Prism Medico Standalone March 2025 Net Sales at Rs 0.07 crore, down 49.86% Y-o-Y
26.11.2024
Prism Medico Standalone September 2024 Net Sales at Rs 0.29 crore, up 780.12% Y-o-Y
05.06.2024
Prism Medico Standalone March 2024 Net Sales at Rs 0.15 crore, down 88.57% Y-o-Y
31.05.2023
Prism Medico Standalone March 2023 Net Sales at Rs 1.27 crore, down 84.95% Y-o-Y
13.06.2025
Prism Medico Standalone March 2025 Net Sales at Rs 0.07 crore, down 49.86% Y-o-Y
26.11.2024
Prism Medico Standalone September 2024 Net Sales at Rs 0.29 crore, up 780.12% Y-o-Y
05.06.2024
Prism Medico Standalone March 2024 Net Sales at Rs 0.15 crore, down 88.57% Y-o-Y
31.05.2023
Prism Medico Standalone March 2023 Net Sales at Rs 1.27 crore, down 84.95% Y-o-Y
17.06.2024
HDFC AMC appoints Harish Narayanan as chief marketing officer and chief digital officer
10.06.2024
HFT Scan : Aditya Birla Money and Tourism Finance Corporation in focus
07.06.2024
HDFC AMC board approves re-appointment of Navneet Munot as MD and CEO for 5 years effective July 1
05.06.2024
Neutral Max Financial Services; target of Rs 1020: Motilal Oswal
16.01.2023
Muthoot Finance Q3 Net Profit may dip 13.8% YoY to Rs. 886.8 cr: Prabhudas Lilladher
16.01.2023
L&T Finance Holdings Q3 Net Profit seen up 51.7% YoY to Rs. 389.2 cr: Prabhudas Lilladher
11.10.2022
Muthoot Finance Q2 Net Profit may dip 16.7% YoY to Rs. 827.9 cr: Prabhudas Lilladher
11.10.2022
L&T Finance Holdings Q2 Net Profit seen up 32.8% YoY to Rs. 229.2 cr: Prabhudas Lilladher